News
-
-
PRESS RELEASE
Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
Marinomed Biotech seeks reorganisation through restructuring proceedings without self-administration due to outstanding earn-out payments and terminated negotiations with Unither Pharmaceuticals -
PRESS RELEASE
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
Marinomed Biotech AG files for court restructuring proceedings without self-administration. Market making contract terminated, affecting share liquidity. Half-year financial report postponed -
-
-
-
PRESS RELEASE
As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
NanoViricides, Inc. applies for Phase II Clinical Trial of NV-387 Oral Gummies as Treatment for Bundibugyo Ebolavirus in DRC, aiming to combat Ebola outbreak with revolutionary antiviral drug -
PRESS RELEASE
Worksport Announces 132% Gross Profit Growth from April to June; June 2026 Marks Strongest Month in Company History
Worksport Ltd. reports a 46% increase in net sales and 132% increase in gross profit from April to June 2026, showing significant progress towards cash-flow breakeven. The company's sustainable gross margin rate is above 35% -
-